在携带致病序列变异的人类Kv1.2通道中恢复酸代谢物的活性
Rían W Manville1, Richard Sidlow2, Geoffrey W Abbott1
1Bioelectricity Laboratory, Department of Physiology and Biophysics, School of Medicine, University of California, Irvine, Irvine, CA, USA.
iScience
|September 2, 2025
概括
酸 (PA) 在治疗KCNA2基因疾病方面具有前景. 这种化合物有效地恢复了功能丧失的Kv1.2通道变体,这表明了潜在的治疗应用.
科学领域:
- 神经科学
- 遗传学
- 药理学
背景情况:
- 编码Kv1.2通道的KCNA2基因序列变异与,认知迟缓和运动障碍有关.
- 功能障碍的Kv1.2通道也与疼痛和肌缩侧面硬化 (ALS) 有关.
- 目前治疗方法直接纠正突变Kv1.2功能是有限的.
研究的目的:
- 将人类的Kv1.2基因变异分类并评估酸 (PA) 的治疗潜力.
- 研究PA对KV1.2通道功能的作用机制.
- 评估PA作为KCNA2相关疾病的化合物.
主要方法:
- 用细胞电生理学将19个人类Kv1.2变体 (致病性或未知意义) 分类为功能丧失 (LOF),功能增加 (GOF) 或混合LOF/GOF.
- 在接中,突变发生和电生理学确定了PA结合部位.
- 在实验室中评估了PA的疗效和临床前毒性.
主要成果:
- 在13/13 LOF和1/1 LOF/ GOF病原性Kv1.2变体中通过超极化它们的电压依赖来成功改善功能.
- 在Kv1.2电压传感器中确定了PA的特定结合点.
- 在临床前,PA的毒性很低.
结论:
- 酸是治疗Kv1.2功能丧失疾病的有前途的化合物.
- 在和其他神经疾病中,PA恢复Kv1.2通道功能是潜在的治疗策略.
- 进一步开发PA可能会为KCNA2相关疾病带来新的治疗方法.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
274
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
274
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.2K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.2K
Non-gated Ion Channels
7.1K
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
7.1K
Voltage-gated Ion Channels
8.6K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.6K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.6K


